
IGF-1
Insulin-like Growth Factor-1
Also called IGF-1, insulin-like growth factor 1, somatomedin C, mecasermin
The hormone GH actually works through
IGF-1 is the hormone that does most of growth hormone's work. Growth hormone tells the liver to make IGF-1, and IGF-1 tells muscle and other tissue to grow. As mecasermin (Increlex) it is approved for children with severe primary IGF-1 deficiency; other uses are not approved, and its main risk is low blood sugar.
The main mediator of growth hormone's effects. Most of what growth hormone does to muscle, tissue and growth is carried out by IGF-1, produced mainly in the liver. Most IGF-1 circulates bound to carrier proteins. As mecasermin (Increlex) it is an approved prescription drug for children with severe primary IGF-1 deficiency.
- Half-life
- Minutes when unbound; hours when carried by binding proteins
- Route studied
- Subcutaneous injection (Increlex label)
- Status
- Prescription as mecasermin (Increlex), for severe primary IGF-1 deficiency in children
Studied in people, and well studied in preclinical models
What IGF-1 has been studied for
The reasons people look it up, roughly in order of how often, and what research exists for each. Interest in a use is not evidence that it works; the evidence is stated under each one.
- Muscle growth
- The main reason people look it up. It signals muscle cells to grow and to take up nutrients. No trial has tested it for muscle growth in healthy adults.
- Recovery from training
- Discussed on the theory that it speeds repair between training sessions. Not tested for this.
- Severe primary IGF-1 deficiency in children
- The approved use, as mecasermin (Increlex), for children whose bodies make growth hormone but cannot respond to it normally.
Mechanism of Action
How IGF-1 works
IGF-1 is the downstream effector of the growth hormone axis:
- IGF-1 receptor (IGF1R) activation. It binds IGF1R and triggers the PI3K/Akt/mTOR pathway that drives protein synthesis, cell growth and repair.
- Growth-hormone-dependent production. Growth hormone signals the liver to produce IGF-1, so most of growth hormone's effect on tissue is really IGF-1's.
- Binding proteins. Native IGF-1 is mostly bound to IGFBP-3, with only a small free, active fraction, unlike the engineered LR3 analogue.
- Shared insulin signalling. IGF1R overlaps with insulin signalling, which is why IGF-1 lowers blood glucose.
IGF-1 side effects: what studies reported
The side-effect profile is well described from the approved drug. IGF-1 acts on machinery shared with insulin, so it lowers blood sugar.
Most commonly reported
- Low blood sugar: shakiness, sweating, sudden hunger, light-headedness
- Injection-site reactions
- Water retention and puffiness
- Aching joints
Worth keeping an eye on
- Numbness or tingling in the hands, from swelling pressing on the nerve at the wrist
- Headaches
- Jaw and facial aching
The one to take seriously
- Blood sugar can fall far enough to be dangerous, which is why the Increlex label ties each dose to a meal
- IGF-1 is a growth signal, and the label contraindicates it in active or suspected cancer
Dose-related findings. Hypoglycaemia is dose-related on the label.
Source: The mecasermin (Increlex) label and clinical experience, plus reports outside trials. This is a summary of published findings, not a complete safety profile and not medical advice. Questions about IGF-1 belong with a licensed clinician who knows your history.
Your Genetics & IGF-1
The genes involved in how IGF-1 works
IGF-1 works through the receptors these genes build, and the genes vary from person to person. Researchers have linked some of that variation to differences in how people respond. A DNA report tells you which versions you carry.
This promoter variant has been associated with differences in baseline IGF-1 levels in population studies. It describes a baseline, not a response to IGF-1 given as a drug.
IGF1R · ••
Builds the IGF-1 receptor. Variants have been studied for their association with IGF-1 levels, height and longevity. Not studied as a predictor of response to IGF-1.
IGFBP3 · ••
The -202 A/C variant has been associated with differences in IGFBP-3, the main IGF-1 carrier protein, in population studies. Pathway context only.
GHR · ••
The exon 3 deletion produces a shorter growth hormone receptor that some studies associated with greater growth hormone sensitivity, upstream of IGF-1 production. Pathway context only.
The dots after each gene are where your own result goes. Your report fills them in with the two letters you carry at that position.
Which of these variants do you carry?
Your report reads the DNA file you already have against this research.
Often discussed alongside
Compounds that come up next to IGF-1 in research and discussion. Each has its own page. None of this is a suggestion to combine them.

IGF-1
an engineered long-acting versionModerate EvidenceInsulin-like Growth Factor-1
The main mediator of growth hormone's effects. Most of what growth hormone does to muscle, tissue and growth is carried out by IGF-1, produced mainly in the liver. Most IGF-1 circulates bound to carrier proteins. As mecasermin (Increlex) it is an approved prescription drug for children with severe primary IGF-1 deficiency.
4
Gene variants
45+
Studies
Access
Access and legal status
IGF-1: Prescription as mecasermin (Increlex), for severe primary IGF-1 deficiency in children. Decisions about any prescription medicine belong to a prescriber. We don't link to any seller, and nothing on this page is a recommendation to obtain or use it.
Your DNA and IGF-1: see which of the variants studied alongside it you carry, and what that research does and does not show. Read my DNA, $99 →
Educational information only, not medical advice. Most peptides are not FDA-approved. Do not start, stop or change any medication or peptide because of this page; talk to a licensed clinician.
Worth knowing about IGF-1
Interactions and situations where there is a specific reason to be careful. Where the honest answer is that nobody has studied something, it says so and says what that leaves open.
- Hypoglycaemia is the main risk
- The Increlex label requires each dose to be given with a meal or snack because of the blood-sugar drop. Severe hypoglycaemia is a medical emergency.
- It is a growth signal, and growth is not selective
- It does not only tell muscle to grow. That is the reason for the cancer caution, and it is not a theoretical one.
Last updated
Frequently Asked Questions
What is the difference between IGF-1 and IGF-1 LR3?
Native IGF-1 is the body's own hormone, mostly bound to carrier proteins, with a short-lived free fraction. IGF-1 LR3 is an engineered analogue that resists those binding proteins and stays active for hours. Both act on the same IGF-1 receptor; the difference is duration and the free fraction.
Why is IGF-1 tied so closely to growth hormone?
Growth hormone exerts most of its tissue effects indirectly, by telling the liver to produce IGF-1. That is why an IGF-1 blood test is used as a practical readout of growth hormone activity.
Do genes affect IGF-1?
Variants in IGF1, IGF1R, IGFBP3 and GHR have been associated with differences in baseline IGF-1 levels in population studies. No study has tested whether they change response to IGF-1 given as a drug. A DNA report can show which versions you carry and what that research does and does not show.
Watch
What clinicians and researchers say about IGF-1
35 minThe Truth About Popular Peptides (What Works, What’s Overhyped) | Peptide Tier List pt.1Alex Tatem · ClinicianBPC-157TB-500IGF-1 LR3
6 minTIER LIST PEPTIDE EDITIONGreg Doucette · CoachIGF-1SemaglutideBPC-157
49 minAre Peptides Freaking Magic For Healing, Recovery, & Everything Else? | Dr Chris Raynor ExplainsChris Raynor · ClinicianBPC-157TB-500CJC-1295Learn more about IGF-1
11 guides mention IGF-1→how it works
In depthThe IGF-1 to IGFBP-3 ratio explained: what it shows that total IGF-1 does not
9 min read
safety
In depth9 signs of high IGF-1, and what the clinical research says each one means
9 min read
peptide guides
MK-677 long-term results: what the 2-year trial and the stopped trial actually found
11 min read
comparisons
Ipamorelin vs CJC-1295: same goal, very different biology
9 min read
peptide guides
Peptides studied for muscle recovery and injury repair: 7 compounds sorted by human evidence
11 min read
genetics
GHR exon 3 deletion: what growth hormone studies found, and what they never tested
9 min read
Your DNA and IGF-1
What the research says about your variants.
The report
Which IGF-1 variants do you carry?
Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show.
Read my DNA, $99